PHENOM CATHETER
Report
- Report Number
- 9617601-2025-03796
- Event Type
- Malfunction
- Date Received
- December 30, 2025
- Date of Event
- December 22, 2025
- Report Date
- January 13, 2026
- Manufacturer
- MEDTRONIC MEXICO S. DE R.L. DE CV
- Product Code
- QJP
- UDI-DI
- 00763000304294
- PMA / PMN Number
- K151638
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CONTINUATION OF D10: PRODUCT ID PED3-021-350-20 (D050452); PRODUCT ID PED3-021-350-16 (D050415); PRODUCT ID FG19120-1030-1S (231481250). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
B5 UPDATED WITH ADDITIONAL INFORMATION RECEIVED. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
IT WAS REPORTED THAT DURING THE DEPLOYMENT OF THE PIPELINE VANTAGE WITH SHIELD TECHNOLOGY FLOW DIVERTER DEVICE FOR THE TREATMENT OF AN UNRUPTURED, FUSIFORM CAROTID TIP ANEURYSM (MAXIMUM DIAMETER 5 MM, NECK DIAMETER 4 MM), IT WAS NOT POSSIBLE TO RESHEATH THE DEVICE DURING THE PROCEDURE, DESPITE NO VISUAL EVIDENCE OF TWISTING. MULTIPLE DEVICES WERE INVOLVED. ATTEMPTS TO RESHEATH THE DEVICE OUTSIDE THE SYSTEM WERE ALSO UNSUCCESSFUL, AND UPON OPENING, INCREASED RADIOPACITY WAS OBSERVED AT THE ZONE INVOLVED IN THE UNSUCCESSFUL RESHEATHING PROCESS. THE PROCEDURE WAS PERFORMED USING TRIAXIAL ACCESS VIA THE FEMORAL ARTERY (DIAMETER 8 MM) WITH NORMAL VESSEL TORTUOSITY, AND DUAL ANTIPLATELET THERAPY (ASA AND PLAVIX) WAS ADMINISTERED. GUIDE CATHETER (INFINITY PLUS) AND GUIDEWIRE (SYNCRO) WERE USED, AND ALL DEVICES AND ACCESSORIES WERE PREPARED AND FLUSHED AS INDICATED IN THE INSTRUCTIONS FOR USE. THE ANGIOGRAPHIC RESULT POST PROCEDURE WAS REPORTED AS GOOD. NO PATIENT SYMPTOMS OR COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. THE LANDING ZONE WAS 3.3 MM DISTAL AND 3.5 MM PROXIMAL.
ADDITIONAL INFORMATION RECEIVED REPORTED THE RESHEATHING ISSUE OCCURRED ONLY WITH THE FIRST PIPELINE (PED3-021-350-20. LOT:D050452) AND THE PHENOM 21 MICRO CATHETER (FG13150-0615-2S, LOT: 229938289). RESISTANCE OCCURRED WITH THE PIPELINE IN THE DISTAL END OF THE PHENOM 21 MICROCATHETER. IT WAS NOTED THAT CONTINUOUS FLUSH WAS ADMINISTERED AND MAINTAINED DURING THE PROCEDURE AS INDICATED IN THE IFU. THERE WAS NO DAMAGE OBSERVED TO THE PIPELINE PUSHWIRE, NOR TO THE PHENOM21 OR PHENOM PLUS CATHETERS. THE SECOND PIPELINE WAS SUCCESSFULLY IMPLANTED TO COMPLETE THE PROCEDURE. THERE WAS NO ISSUE REPORTED INVOLVING THE PHENOM PLUS CATHETER (FG19120-1030-1S, LOT: 231481250) OR THE SECOND/IMPLANTED PIPELINE (PED3-021-350-16, LOT: D050415).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 177195 | PHENOM CATHETER | CATHETER, PERCUTANEOUS, NEUROVASCULATURE | QJP | MEDTRONIC MEXICO S. DE R.L. DE CV | FG13150-0615-2S | 229938289 | 00763000304294 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 54 YR | Male | SEE H11... |